Skip to main content

ORIGINAL RESEARCH article

Front. Tuberc
Sec. Epidemiology of Tuberculosis
Volume 2 - 2024 | doi: 10.3389/ftubr.2024.1433856

Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon

Provisionally accepted
Chefor Magha Chefor Magha 1NCHANG LUCY CHO NCHANG LUCY CHO 1Michael Weldeslassie Michael Weldeslassie 2Desmond A. Nkimbeng Desmond A. Nkimbeng 1Nancielle M. Tchatat Nancielle M. Tchatat 1Henry D. Meriki Henry D. Meriki 1Kebede Deribe Kebede Deribe 3Franck Noel Nietcho Franck Noel Nietcho 1Juluis Visnel Foyet Juluis Visnel Foyet 1Fanny F. Fombad Fanny F. Fombad 1Tatiana D. Katcho Tatiana D. Katcho 1Jerome F. Cho Jerome F. Cho 1Eyoab Iyasu Eyoab Iyasu 2Simon Waddell Simon Waddell 3Kidist Bobosha Kidist Bobosha 4Melanie Newport Melanie Newport 3Achim Hoerauf Achim Hoerauf 5Manuel Ritter Manuel Ritter 5*Samuel Wanji Samuel Wanji 1*
  • 1 Parasite and Vector Research Unit, Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon
  • 2 Independent researcher, Mai Nefhi, Eritrea
  • 3 Brighton and Sussex Medical School, Brighton, England, United Kingdom
  • 4 Armauer Hansen Research Institute (AHRI), Addis Ababa, Addis Ababa, Ethiopia
  • 5 Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany

The final, formatted version of the article will be published soon.

    Comorbid non-communicable diseases (NCDs) like diabetes, cardiovascular diseases (CVD), kidney diseases, and hypertension, could have implications for tuberculosis (TB) treatment management and increase the disease burden amongst active TB patients. This cross-sectional study aimed at profiling comorbidities amongst sputum-positive TB patients in the South West and Littoral regions of Cameroon and was relevant for improving disease management and public health interventions.Diabetes was defined by elevated blood glucose, body mass index and hypertension by elevated blood pressure levels (i.e., systolic ≥130mmHg or diastolic ≥80mmHg). Socio-demographic and clinical data were collected using case report forms. Descriptive analysis was performed, bivariate logistic regression analysis was computed with at least one comorbidity as the dependent variable (global model) and a multivariable logistic regression analysis was done to provide adjusted odds ratios (final model). The covariate with the highest p-value was removed until p ˂ 0.25 cut-off, using R software version 4.3.1. P-value ˂ 0.05 at 95 % confidence interval was considered statistically significant. Five hundred and forty-nine sputum-positive microscopically confirmed active TB patients were enrolled into this study. Two-thirds (65.8%) of the total patients were male. Overall, 56 sputumpositive TB patients had at least one non-communicable disease, thus a prevalence of 10.2 % (95 % CI = 7.9 -13.0). The most frequently recorded NCD was diabetes 4.4 % (95 % CI = 3.1 -6.7) followed by kidney disease 2 % (95 % CI = 1.1 -3.6), hypertension 0.9 % (95 % CI = 0.4 -2.2), and CVD 0.91 % (95 % CI = 0.4 -2.2). Three TB patients (0.6 %) had all four comorbidities examined. Age group (p < 0.001), and level of education (p = 0.049) were factors significantly associated with having at least one comorbidity. Our findings showed that diabetes was significantly the most prevalent comorbid NCD amongst sputum-positive TB patients (p < 0.001). HIV status, occupation, body mass index (BMI), and alcohol intake were not significantly associated with having at least one comorbidity.Implementing public health intervention programmes such as systematic screening of TB patients for NCDs especially diabetes is highly recommended for better control of these diseases.

    Keywords: Mycobacterium tuberculosis, comorbidities, Non-communicable diseases, Tuberculosis, diabetes, cardiovascular disease, kidney disease

    Received: 17 May 2024; Accepted: 02 Sep 2024.

    Copyright: © 2024 Magha, CHO, Weldeslassie, Nkimbeng, Tchatat, Meriki, Deribe, Nietcho, Foyet, Fombad, Katcho, Cho, Iyasu, Waddell, Bobosha, Newport, Hoerauf, Ritter and Wanji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Manuel Ritter, Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, 53127, North Rhine-Westphalia, Germany
    Samuel Wanji, Parasite and Vector Research Unit, Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.